How a gut bacterium helps manage inflammation and diabetes
Understanding the molecular mechanisms of Akkermansia glycan-binding adhesins in shaping microbial communities and balancing intestinal inflammation in response to host signals
This study is looking at a friendly gut bacterium called Akkermansia muciniphila to see how it helps keep our intestines healthy and may prevent issues like type-2 diabetes and colorectal cancer, which could lead to new ways to manage inflammation and related health problems.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oregon NIH-funded |
| Lab location | 1 site (Eugene, United States) |
| Project ID | NIH-10875536 on NIH RePORTER |
What this research studies
This research investigates the role of a specific gut bacterium, Akkermansia muciniphila, in maintaining intestinal health and preventing chronic inflammatory diseases like type-2 diabetes and colorectal cancer. By examining how this bacterium interacts with the mucin lining of the intestine and produces beneficial compounds, the study aims to uncover the molecular mechanisms that support its health-promoting properties. The research involves culturing the bacterium in a controlled environment to observe its behavior and effects on other gut microbes, which may lead to new therapeutic strategies for managing inflammation and related diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults suffering from inflammatory conditions such as type-2 diabetes or inflammatory bowel diseases.
Not a fit: Patients with non-inflammatory gastrointestinal disorders or those without chronic diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that harness the power of gut bacteria to reduce inflammation and improve health outcomes for patients with chronic diseases.
How similar studies have performed: Previous research has shown promising results in using gut bacteria to influence health, suggesting that this approach could lead to significant advancements in treatment.
Where this research is happening
Eugene, United States
- University of Oregon — Eugene, United States (Active)
Researchers
- Principal investigator: Smith, Timothy Jarrod — University of Oregon
- Study coordinator: Smith, Timothy Jarrod
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.